Logos Global Management »

Pharvaris N V shares owned by Logos Global Management

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 100k 27.75
2025-09-30 $3.7M 150k 24.95

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences (IDYA)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)
Cidara Therapeutics Com New (CDTX)
Abivax Sa Sponsored Ads (ABVX)
Erasca (ERAS)
Ocular Therapeutix (OCUL)
Structure Therapeutics Sponsored Ads (GPCR)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Tango Therapeutics (TNGX)
Avidity Biosciences Ord (RNA)
Biogen Idec (BIIB)
Immunovant (IMVT)

View all positions for Logos Global Management

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Deerfield Management Company
Bain Capital Life Sciences Investors
Commodore Capital
Novo A/S
Wellington Management Company
Saturn V Capital Management
Cormorant Asset Management
5AM Venture Management
Sofinnova Ventures

View all funds holding Pharvaris N V